Associate Professor of Medicine
Fellowship Director, Infectious Diseases
The University of Connecticut Health Center
- Antiretroviral therapies
- HIV and aging
- HIV testing
- HIV and coinfections
- Viral hepatitis
Dr Chirch is Associate Professor in the Division of Infectious Diseases at the University of Connecticut Health Center and School of Medicine. Dr Chirch currently serves as the Infectious Diseases Fellowship Program Director, and has published a variety of papers, chapters, and reviews on HIV and antiretroviral therapy, and also lectures regionally on these topics.
Hepatitis C Utilization Review Board – Correctional Managed Health Care at UConn Health Center
The University of Connecticut School of Medicine Graduate Medical Education Committee
- New England AIDS Education and Training Center
Infectious Diseases Society of AmericaAmerican Board of Internal Medicine
- Excellence in Medical Student Education in the Student Continuity Practice - UConn Health Center
- Wesley Older Award for Outstanding Resident Physician - Georgetown University Medical Center
- Phi Beta Kappa, Magna Cum Laude, Georgetown University (1994)
- Georgetown University School of Languages and Linguistics, BS (1994)
- State University of New York Upstate Medical University College of Medicine, MD (1995-1999)
- Georgetown University Medical Center, Residency in Internal Medicine (1999-2002)
- Stony Brook University Hospital, Fellowship in Infectious Diseases (2003-2005)
1. Chirch LM, Hasham M, Kuchel GA HIV and aging: a clinical journey from Koch's postulate to the chronic disease model and the contribution of geriatric syndromes. Curr Opin HIV AIDS. 2014 Jul;9(4):405-11.
2. Cloherty G, Swanson P, Lucic D, Dieckhaus K, Anthony P, Cataline P, Herman C, Hackett J Jr, Skolnik PR, Chirch L. Clinical implications of elevated HIV-1 viral load results obtained from samples stored frozen in vacutainer plasma preparation tubes. Journal of Virological Methods 204 (2014) 91–92.
3. Gemtessa TA and Chirch LM. Update on Hepatitis C Virus and HIV Coinfection. Journal of Clinical and Translational Hepatology 2013 vol. 1 | 109–115.
4. Chirch LM, Steigbigel RT. Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection. Infection and Drug Resistance. 2010;3:15-23.
5. Chirch LM, Morrison S, Steigbigel RT. Treatment of HIV infection with raltegravir. Expert Opin Pharmacother. 2009;10:1203-1211.
6. Chirch LM, Luft BJ. Cerebral toxoplasmosis in AIDS. In: Portegies P, Berger JR, eds. HIV/AIDS and the Nervous System. 3rd ed. Elsevier BV; 2007.
7. Chirch LM, Feiner J, Go R, et al. Osteopenia in patients with HIV infection is not associated with elevated sTNFR2 levels. Clin Infect Dis. 2006;43:1084-1085.